{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:27:05Z","timestamp":1794608825149,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["1H79TI081697"],"award-info":[{"award-number":["1H79TI081697"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Behav Health Serv Res"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s11414-021-09783-z","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T19:04:20Z","timestamp":1642705460000},"page":"165-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["To Prescribe or Not to Prescribe?: Barriers and Motivators for Progressing Along Each Stage of the Buprenorphine Training and Prescribing Path"],"prefix":"10.1007","volume":"50","author":[{"given":"Rachel P.","family":"Winograd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Woolfolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinith","family":"Ilavarasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Liss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Stringfellow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"9783_CR1","unstructured":"National Center for Health Statistics. Provisional drug overdose death counts. Centers for Disease Control and Prevention. Available online at https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2021\/20210714.htm. Accessed on November 18, 2021."},{"issue":"3","key":"9783_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","volume":"169","author":"MR Larochelle","year":"2018","unstructured":"Larochelle, M. R., Bernson, D., Land, T., el al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Annals of Internal Medicine. 2018;169(3):137-145.","journal-title":"Annals of Internal Medicine."},{"key":"9783_CR3","first-page":"1","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo, L., Barrio, G., Bravo, M. J., et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:1-14.","journal-title":"BMJ."},{"issue":"2","key":"9783_CR4","first-page":"e1920622","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman, S. E., Larochelle, M. R., Ameli, O., et al. Comparative effectiveness of different treatment pathways for opioid use disorder. Journal of the American Medical Association Network Open. 2020;3(2):e1920622-e1920622.","journal-title":"Journal of the American Medical Association Network Open."},{"issue":"1","key":"9783_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jsat.2006.11.009","volume":"33","author":"I Maremmani","year":"2007","unstructured":"Maremmani I, Pani PP, Pacini M, et al. Substance use and quality of life over 12 months among Buprenorphine maintenance-treated and Methadone maintenance-treated Heroin-addicted patients. Journal of Substance Abuse Treatment. 2007; 33(1):91-98.","journal-title":"Journal of Substance Abuse Treatment."},{"key":"9783_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.04.005","volume":"78","author":"AS Huhn","year":"2017","unstructured":"Huhn, A. S., & Dunn, K. E. Why Aren't physicians prescribing more buprenorphine?. Journal of Substance Abuse Treatment. 2017;78: 1-7.","journal-title":"Journal of Substance Abuse Treatment."},{"key":"9783_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","volume":"160","author":"BJH Yarborough","year":"2016","unstructured":"Yarborough, B. J. H., Stumbo, S. P., McCarty, D., et al. Methadone, buprenorphine and preferences for opioid agonist treatment: a qualitative analysis. Drug and Alcohol Dependence. 2016;160: 112-118.","journal-title":"Drug and Alcohol Dependence."},{"key":"9783_CR8","unstructured":"Racial Disparities in opioid addiction treatment: primer & research roundup. The Journalist\u2019s Resource. Available online at https:\/\/journalistsresource.org\/home\/systemic-racism-opioid-addiction-treatment\/. Accessed on July 14, 2021."},{"issue":"3","key":"9783_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","volume":"40","author":"HB Hansen","year":"2013","unstructured":"Hansen, H. B., Siegel, C. E., Case, B. G., et al. Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City. The Journal of Behavioral Health Services & Research. 2013;40(3): 367\u2013377. https:\/\/doi.org\/10.1007\/s11414-013-9341-3","journal-title":"The Journal of Behavioral Health Services & Research."},{"key":"9783_CR10","unstructured":"Biden Administration Finalizes Buprenorphine Practice Guidelines: a step in the right direction. American College of Emergency Physicians. Available online at https:\/\/www.acep.org\/federal-advocacy\/federal-advocacy-overview\/regs--eggs\/regs--eggs-articles\/regs--eggs---april-29-2021\/. Accessed on July 14, 2021."},{"issue":"1","key":"9783_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jrh.12307","volume":"35","author":"CHA Andrilla","year":"2019","unstructured":"Andrilla, C. H. A., Moore, T. E., Patterson, D. G., et al. Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update. The Journal of Rural Health. 2019;35(1): 108-112.","journal-title":"The Journal of Rural Health."},{"issue":"8","key":"9783_CR12","first-page":"e2014045","volume":"3","author":"A Duncan","year":"2020","unstructured":"Duncan, A., Anderman, J., Deseran, T., et al. Monthly patient volumes of buprenorphine-waivered clinicians in the US. Journal of the American Medical Association Network Open. 2020;3(8):e2014045-e2014045.","journal-title":"Journal of the American Medical Association Network Open."},{"key":"9783_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.drugalcdep.2017.10.002","volume":"181","author":"CP Thomas","year":"2017","unstructured":"Thomas, C. P., Doyle, E., Kreiner, P. W., et al. Prescribing patterns of buprenorphine waivered physicians. Drug and Alcohol Dependence. 2017;181:213-218.","journal-title":"Drug and Alcohol Dependence."},{"issue":"4","key":"9783_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/MLR.0000000000000703","volume":"55","author":"H Wen","year":"2017","unstructured":"Wen, H., Hockenberry, J. M., Borders, T. F., et al. Impact of medicaid expansion on medicaid-covered utilization of buprenorphine for opioid use disorder treatment. Medical Care. 2017;55(4):336-341.","journal-title":"Medical Care."},{"issue":"2","key":"9783_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1370\/afm.1595","volume":"12","author":"E Hutchinson","year":"2014","unstructured":"Hutchinson, E., Catlin, M., Andrilla, C. H. A., et al. Barriers to primary care physicians prescribing buprenorphine. The Annals of Family Medicine. 2014;12(2):128-133.","journal-title":"The Annals of Family Medicine."},{"key":"9783_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2016.10.005","volume":"74","author":"A Kermack","year":"2017","unstructured":"Kermack, A., Flannery, M., Tofighi, B., et al. Buprenorphine prescribing practice trends and attitudes among New York providers. Journal of Substance Abuse Treatment. 2017;74:1-6.","journal-title":"Journal of Substance Abuse Treatment."},{"key":"9783_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7832752","volume":"2019","author":"LA Marino","year":"2019","unstructured":"Marino, L. A., Campbell, A. N., Nunes, E. V., et al. Factors influencing buprenorphine prescribing among physicians in New York State. Journal of Addiction. 2019;2019:1-5.","journal-title":"Journal of Addiction."},{"issue":"1","key":"9783_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jsat.2014.07.010","volume":"48","author":"BD Stein","year":"2015","unstructured":"Stein, B. D., Gordon, A. J., Dick, A. W., et al. Supply of buprenorphine waivered physicians: the influence of state policies. Journal of Substance Abuse Treatment. 2015;48(1):104-111.","journal-title":"Journal of Substance Abuse Treatment."},{"issue":"3","key":"9783_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/add.14436","volume":"114","author":"CM Jones","year":"2019","unstructured":"Jones, C. M., & McCance-Katz, E. F. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder. Addiction. 2019;114(3):471-482.","journal-title":"Addiction."},{"key":"9783_CR20","unstructured":"Rural Health Information Hub. What is Rural? Health resources and services administration. Available online at https:\/\/www.ruralhealthinfo.org\/topics\/what-is-rural#goldsmith-modification. Accessed on July 14, 2021."},{"issue":"6","key":"9783_CR21","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.amepre.2018.02.006","volume":"54","author":"CH Andrilla","year":"2018","unstructured":"Andrilla, C. H., Coulthard, C., & Patterson, D. G. Prescribing practices of rural physicians waivered to prescribe buprenorphine. American Journal of Preventive Medicine. 2018;54(6):S208-S214. https:\/\/doi.org\/10.1016\/j.amepre.2018.02.006","journal-title":"American Journal of Preventive Medicine."},{"issue":"6","key":"9783_CR22","doi-asserted-by":"publisher","first-page":"S230","DOI":"10.1016\/j.amepre.2017.12.022","volume":"54","author":"RL Haffajee","year":"2018","unstructured":"Haffajee, R. L., Bohnert, A. S., & Lagisetty, P. A. Policy pathways to address provider workforce barriers to buprenorphine treatment. American Journal of Preventive Medicine. 2018;54(6):S230-S242.","journal-title":"American Journal of Preventive Medicine."},{"key":"9783_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13722-017-0072-2","volume":"12","author":"EP Bhatraju","year":"2017","unstructured":"Bhatraju, E.P., Grossman, E., Tofighi, B., et al. Public sector low threshold office-based buprenorphine treatment: outcomes at year 7. Addiction Science & Clinical Practice. 2017; 12:7.","journal-title":"Addiction Science & Clinical Practice."},{"key":"9783_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jsat.2019.06.010","volume":"104","author":"NJ Presnall","year":"2019","unstructured":"Presnall, N. J., Wolf, D. P. S., Brown, D. S., et al. A comparison of buprenorphine and psychosocial treatment outcomes in psychosocial and medical settings. Journal of Substance Abuse Treatment. 2019;104:135-143.","journal-title":"Journal of Substance Abuse Treatment."},{"issue":"12","key":"9783_CR25","doi-asserted-by":"publisher","first-page":"e0244401","DOI":"10.1371\/journal.pone.0244401","volume":"15","author":"D Rice","year":"2020","unstructured":"Rice, D., Corace, K., Wolfe, D., et al. Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: a systematic review with network meta-analyses. PLOS ONE. 2020;15(12): e0244401.","journal-title":"PLOS ONE."},{"issue":"2","key":"9783_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/1073110518782949","volume":"46","author":"K James","year":"2018","unstructured":"James, K., & Jordan, A. The opioid crisis in black communities. Journal of Law, Medicine & Ethics. 2018;46(2):404\u2013421. https:\/\/doi.org\/10.1177\/1073110518782949","journal-title":"Journal of Law, Medicine & Ethics."},{"issue":"5","key":"9783_CR27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/0033354919863430","volume":"134","author":"J Steinberg","year":"2019","unstructured":"Steinberg, J., Azofeifa, A., & Sigounas, G. Mobilizing primary care to address the opioid use disorder treatment gap. Public Health Reports. 2019;134(5):456-460.","journal-title":"Public Health Reports."},{"key":"9783_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.drugalcdep.2018.09.007","volume":"193","author":"TJ Cicero","year":"2018","unstructured":"Cicero, T. J., Ellis, M. S., & Chilcoat, H. D. Understanding the use of diverted Buprenorphine. Drug and Alcohol Dependence. 2018;193:117-123.","journal-title":"Drug and Alcohol Dependence."},{"issue":"10","key":"9783_CR29","first-page":"e1913818","volume":"2","author":"B Clark","year":"2019","unstructured":"Clark, B., Kai, M., Dix, R., et al. Association of a multimodal educational intervention for primary care physicians with prescriptions of buprenorphine for opioid use disorders. Journal of the American Medical Association Network Open. 2019;2(10):e1913818-e1913818.","journal-title":"Journal of the American Medical Association Network Open."},{"key":"9783_CR30","doi-asserted-by":"crossref","unstructured":"Banks, D. E., Carpenter, R. W., Wood, C. A., et al. Commentary on Furr-Holden et al.: As opioid overdose deaths accelerate among Black Americans, COVID-19 widens inequities\u2014a critical need to invest in community-based approaches. Addiction. 2021;116(3):686-687.","DOI":"10.1111\/add.15362"}],"container-title":["The Journal of Behavioral Health Services & Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11414-021-09783-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11414-021-09783-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11414-021-09783-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T13:14:19Z","timestamp":1676553259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11414-021-09783-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["9783"],"URL":"https:\/\/doi.org\/10.1007\/s11414-021-09783-z","relation":{},"ISSN":["1094-3412","1556-3308"],"issn-type":[{"value":"1094-3412","type":"print"},{"value":"1556-3308","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"30 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}